Lows April News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lows april. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lows April Today - Breaking & Trending Today

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ABIOMED, Inc. (NASDAQ:ABMD) - The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx


ShockWave Medical, Inc. (NASDAQ: SWAV)
Verastem, Inc. (NASDAQ: VSTM)
Down In The Dumps
Akoya Biosciences, Inc. (NASDAQ: AKYA)
Decibel Therapeutics, Inc. (NASDAQ: DBTX)
IRadimed Corporation (NASDAQ: IRMD)
Lucira Health, Inc. (NASDAQ: LHDX)
Mesoblast Limited (NASDAQ: MESO)
Protara Therapeutics, Inc. (NASDAQ: TARA)
PTC Therapeutics, Inc. (NASDAQ: PTCT)
Stocks In Focus
Adverum Shares Sink On Serious Adverse Event 
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
This event occurred 30 weeks after randomization in one patient treated with a single intravitreal injection of the high dose of ADVM-022 who has developed hypotony, with panuveitis and loss of vision in the treated eye. ....

United States , Auburn Hills , Dominican Republic , Protalix Bio , Axonics Inc , Jabil Inc , American Society Of Gene Cell Therapy , Ardelyx Inc , Biogen Inc , Nuvasive Inc , Therapeutics Inc , Celcuity Inc , Moderna Inc , Mimedx Group Inc , Galera Therapeutics Inc , Macrogenics Inc , Fite Biopharma Ltd , Insulet Corporation , Lucira Health Inc , Verastem Inc , Eye Disorder Program , Iradimed Corporation , Lantheus Holdings Inc , Boston Scientific Corporation , Alimera Sciences Inc , Health Sciences Inc ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (AKYA) - The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping

{{following ? Following : Follow }} Share: Scaling The Peaks Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (announced a positive readout for allergic conjunctivitis drug) Celcuity Inc. (NASDAQ: CELC) Celldex Therapeutics, Inc. CLDX) Ibere Pharmaceuticals (NYSE: IBER) Insulet Corporation (NASDAQ: PODD) Integra LifeSciences Holdings Corporation (NASDAQ: IART) IRadimed Corporation (NASDAQ: IRMD) Lantheus Holdings, Inc. (NASDAQ: LNTH) MacroGenics, Inc. (NASDAQ: MGNX) Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) NeuroPace, Inc. (NASDAQ: NPCE) (IPOed Thursday) NovoCure Limited (NASDAQ: NVCR) PLx Pharma Inc. (NASDAQ: PLXP) Seelos Therapeutics, Inc. (NASDAQ: SEEL) ShockWave Medical, Inc. (NASDAQ: SWAV) Treace Medical Concepts, Inc. (NASDAQ: TMCI) (IPOed Friday) Verastem, Inc. (NASDAQ: VSTM) Vericel Corporation (NASDAQ: VCEL) ....

Stanford University , United States , San Diego , Biopharma Neurmedix , Eli Lilly , Hidradenitis Suppurativa , Surmodics Inc , Stanford University School Of Medicine , Health Inc , Centers For Medicare , Finch Therapeutics Group Inc , Apellis Pharmaceuticals Inc , Pfizer Inc , Therapeutics Inc , Mimedx Group Inc , Protalix Biotherapeutics Inc , Trillium Therapeutics Inc , Osmotica Pharmaceuticals , Roche Holding , Longboard Pharmaceuticals Inc , Provention Bio Inc , Boston Scientific Corporation , Alimera Sciences Inc , Amplyx Pharmaceuticals Inc , Neurmedix Inc , Dermtech To Collaborate With Stanford Medical School ,